Lacosamide Tablet, Film Coated
Product Images NDC 70518-4562

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 70518-4562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Mm1 (Lacosamide 100mg 70518 4562 00)

Mm1 (Lacosamide 100mg 70518 4562 00)
This is a description of Lacosamide Tablet C-V, 100 mg, with a quantity of 30 per box. The NDC number is 70518-4562-00. The drug is manufactured by Westminster Pharma and repackaged by RemedyRepack Inc. The usual dosage information can be found in the insert. It is recommended to keep this medication away from children and store it at a temperature between 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F) as per USP guidelines.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is information about Lacosamide Tablet C-V, 100 mg, with a quantity of 1 tablet. The NDC number is 70518-4562-01. It includes caution for the drug being for prescription use only, and storage recommendations.*
FDA Label Image

Chemical Structure (Lacosamide 01)

Chemical Structure (Lacosamide 01)
FDA Label Image

Figure 1 (Lacosamide 02)

Figure 1 (Lacosamide 02)
FDA Label Image

Figure 2 (Lacosamide 03)

Figure 2 (Lacosamide 03)
The text describes a figure showing the proportion of patients categorized by Responder Rate for Lacosamide and Placebo groups in Studies 2, 3, and 4. It includes the Responder Rate percentages for different dosages of Lacosamide and Placebo as well as the total number of patients in each group. The figure presents a comparison of the response rates among the different treatment groups.*
FDA Label Image

Figure 3 (Lacosamide 04)

Figure 3 (Lacosamide 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.